Santhera Pharmaceuticals (SPHDF) Short Interest Ratio & Short Volume $17.54 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Santhera Pharmaceuticals Short Interest DataSanthera Pharmaceuticals (SPHDF) has a short interest of 15,600 shares. This marks a 168.97% increase in short interest from the previous month. The short interest ratio (days to cover) is 52.0, indicating that it would take 52.0 days of the average trading volume of 240 shares to cover all short positions.Current Short Interest15,600 sharesPrevious Short Interest5,800 sharesChange Vs. Previous Month+168.97%Dollar Volume Sold Short$256,620.00Short Interest Ratio52.0 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume0 sharesAverage Trading Volume240 sharesToday's Volume Vs. Average0% Short Selling Santhera Pharmaceuticals? Sign up to receive the latest short interest report for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSPHDF Short Interest Over TimeSPHDF Days to Cover Over TimeSPHDF Percentage of Float Shorted Over Time Santhera Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202515,600 shares $256,620.00 +169.0%N/A52 $16.45 3/31/20255,800 shares $98,658.00 -20.6%N/A58 $17.01 3/15/20257,300 shares $116,800.00 +102.8%N/A73 $16.00 2/28/20253,600 shares $33,912.00 +300.0%N/A0 $9.42 2/15/2025900 shares $8,478.00 +12.5%N/A0 $9.42 1/31/2025800 shares $7,536.00 +100.0%N/A0 $9.42 1/15/2025400 shares $3,768.00 -66.7%N/A0.5 $9.42 12/31/20241,200 shares $11,304.00 +50.0%N/A6 $9.42 12/15/2024800 shares $7,536.00 +700.0%N/A4 $9.42 11/30/2024100 shares $1,170.00 No ChangeN/A0 $11.70 Get the Latest News and Ratings for SPHDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024100 shares $1,170.00 No ChangeN/A0 $11.70 10/31/2024100 shares $1,170.00 No ChangeN/A0 $11.70 10/15/2024100 shares $1,170.00 No ChangeN/A0 $11.70 9/30/2024100 shares $1,170.00 No ChangeN/A0 $11.70 9/15/2024100 shares $1,170.00 No ChangeN/A1 $11.70 8/31/2024100 shares $1,170.00 -99.9%N/A0 $11.70 8/15/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 7/31/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 7/15/202479,900 shares $934,830.00 -3.6%N/A799 $11.70 6/30/202482,900 shares $969,930.00 +3.8%N/A0 $11.70 6/15/202479,900 shares $934,830.00 No ChangeN/A0 $11.70 5/31/202479,900 shares $934,830.00 -2.3%N/A0 $11.70 5/15/202481,800 shares $957,060.00 -5.9%N/A818 $11.70 4/30/202486,900 shares $1.02 million +8.1%N/A0 $11.70 4/15/202480,400 shares $940,680.00 -2.1%N/A160.8 $11.70 3/31/202482,100 shares $960,570.00 +1.4%N/A0 $11.70 3/15/202481,000 shares $947,700.00 +1.4%N/A0 $11.70 2/29/202479,900 shares $934,830.00 -5.2%N/A799 $11.70 2/15/202484,300 shares $948,375.00 -0.8%N/A843 $11.25 1/15/202483,700 shares $979,290.00 -5.0%N/A0 $11.70 12/31/202388,100 shares $1.03 million -8.1%N/A28.9 $11.70 12/15/202395,900 shares $1.12 million -6.4%N/A239.8 $11.70 11/30/2023102,500 shares $1.37 million -19.4%N/A0 $13.35 11/15/2023127,200 shares $1.70 million -6.7%N/A0 $13.35 10/31/2023136,400 shares $1.82 million +69.0%N/A104.9 $13.35 10/15/202380,700 shares $758,580.00 No ChangeN/A403.5 $9.40 9/30/202380,700 shares $54,876.00 -2.3%N/A403.5 $0.68 9/15/202382,600 shares $850,119.20 -0.2%N/A0 $10.29 8/31/202382,800 shares $56,304.00 -27.6%N/A10353.9 $0.68 8/15/2023114,300 shares $77,724.00 No ChangeN/A0 $0.68The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 6/30/20231,143,400 shares $7.78 million +254.3%N/A357.3 $6.80 6/15/2023322,700 shares $219,436.00 -7.4%N/A0 $0.68 5/31/2023348,500 shares $236,980.00 +20.5%N/A0 $0.68 5/15/2023289,200 shares $196,656.00 +18.5%N/A0 $0.68 4/30/2023244,000 shares $165,920.00 +0.1%N/A406.7 $0.68 4/15/2023243,800 shares $165,784.00 -3.1%N/A348.3 $0.68 3/31/2023251,700 shares $302,040.00 -28.4%N/A0 $1.20 3/15/2023351,500 shares $421,800.00 -0.7%N/A0 $1.20 2/28/2023354,000 shares $424,800.00 -10.1%N/A0 $1.20 2/15/2023393,700 shares $472,440.00 -1.9%N/A0 $1.20 1/31/2023401,500 shares $481,800.00 -1.6%N/A0 $1.20 1/15/2023407,900 shares $489,480.00 -27.8%N/A4079 $1.20 12/30/2022564,900 shares $796,509.00 +328.9%N/A282.5 $1.41 12/15/2022131,700 shares $185,697.00 +0.8%N/A0 $1.41 11/30/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 11/15/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 10/31/2022130,700 shares $184,287.00 No ChangeN/A0 $1.41 10/15/2022130,700 shares $184,287.00 +312.3%N/A130.7 $1.41 9/30/202231,700 shares $44,697.00 -97.0%N/A0 $1.41 9/15/20221,062,900 shares $1.50 million +8.1%N/A265.7 $1.41 8/31/2022983,000 shares $1.39 million +6.5%N/A0 $1.41 8/15/2022923,300 shares $1.30 million +4.5%N/A0 $1.41 7/31/2022883,700 shares $1.25 million -0.1%N/A0 $1.41 7/15/2022884,900 shares $1.25 million +0.1%N/A0 $1.41 6/30/2022883,700 shares $1.25 million No ChangeN/A0 $1.41 6/15/2022883,700 shares $1.25 million +0.1%N/A0 $1.41 5/31/2022882,700 shares $1.24 million -6.0%N/A0 $1.41 5/15/2022938,600 shares $1.32 million +2.4%N/A0 $1.41 4/30/2022916,500 shares $1.29 million +1.1%N/A0 $1.41 4/15/2022906,300 shares $1.28 million -5.5%N/A0 $1.41 3/31/2022959,500 shares $1.35 million +11.7%N/A0 $1.41 3/15/2022859,200 shares $1.21 million -10.6%N/A0 $1.41 2/28/2022960,700 shares $1.35 million +13.4%N/A0 $1.41 2/15/2022847,300 shares $1.19 million -0.6%N/A0 $1.41 1/31/2022852,800 shares $1.20 million +1.4%N/A0 $1.41 1/15/2022841,200 shares $1.19 million +6.3%N/A0 $1.41 12/31/2021791,300 shares $1.12 million -0.5%N/A3956.5 $1.41 12/15/2021794,900 shares $1.11 million -2.9%N/A0 $1.40 11/30/2021818,500 shares $1.15 million +4.5%N/A125.9 $1.40 11/15/2021783,100 shares $1.07 million +6.0%N/A195.8 $1.37 10/29/2021738,800 shares $1.03 million +0.2%N/A7388 $1.40 10/15/2021737,300 shares $1.13 million -1.5%N/A491.5 $1.53 9/30/2021748,800 shares $1.18 million +4.0%N/A832 $1.58 9/15/2021720,000 shares $1.61 million +30.6%N/A720 $2.23 8/31/2021551,200 shares $1.38 million +8.5%N/A212 $2.50 8/13/2021507,900 shares $1.16 million -1.1%N/A84.7 $2.28 7/30/2021513,500 shares $1.28 million +7.0%N/A88.5 $2.50 7/15/2021479,800 shares $1.28 million +9.4%N/A154.8 $2.67 6/30/2021438,400 shares $1.32 million +11.2%N/A438.4 $3.00 6/15/2021394,300 shares $1.12 million +1.2%N/A34.3 $2.85The Man I Turn to In Times Like This (Ad)A storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when publisher Brett Aitken turns to Whitney Tilson—a man CNBC once dubbed “The Prophet.” Tilson just released a new prediction that runs counter to what mainstream finance is telling you.Market chaos? Hear Tilson’s take now 5/28/2021389,800 shares $955,010.00 +11.8%N/A18.4 $2.45 5/14/2021348,700 shares $958,925.00 +19.5%N/A166 $2.75 4/30/2021291,800 shares $854,974.00 -9.5%N/A1459 $2.93 4/15/2021322,500 shares $983,625.00 -0.2%N/A3225 $3.05 3/31/2021323,100 shares $1.03 million +5.4%N/A190.1 $3.20 3/15/2021306,600 shares $1.01 million +0.8%N/A340.7 $3.30 2/26/2021304,200 shares $1.09 million +9.5%N/A144.9 $3.58 2/12/2021277,800 shares $1.47 million +10.8%N/A99.2 $5.29 1/29/2021250,700 shares $839,845.00 -0.4%N/A192.8 $3.35 1/15/2021259,300 shares $799,940.50 +2.6%N/A46.3 $3.09 12/31/2020252,300 shares $761,946.00 -2.7%N/A45.9 $3.02 12/15/2020259,300 shares $785,679.00 +2.6%N/A46.3 $3.03 11/30/2020252,800 shares $793,792.00 +19.4%N/A57.5 $3.14 11/15/2020211,800 shares $677,760.00 -68.7%N/A13.1 $3.20 10/30/2020677,300 shares $2.42 million +38.4%N/A376.3 $3.58 10/15/2020489,300 shares $1.74 million +38.4%N/A181.2 $3.55 9/30/2020353,600 shares $1.58 million +3.2%N/A589.3 $4.47 SPHDF Short Interest - Frequently Asked Questions What is Santhera Pharmaceuticals' current short interest? Short interest is the volume of Santhera Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 15,600 shares of SPHDF short. Learn More on Santhera Pharmaceuticals' current short interest. What is a good short interest ratio for Santhera Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPHDF shares currently have a short interest ratio of 52.0. Learn More on Santhera Pharmaceuticals's short interest ratio. Is Santhera Pharmaceuticals' short interest increasing or decreasing? Santhera Pharmaceuticals saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 15,600 shares, an increase of 169.0% from the previous total of 5,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Santhera Pharmaceuticals stock? Short selling SPHDF is an investing strategy that aims to generate trading profit from Santhera Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Santhera Pharmaceuticals? A short squeeze for Santhera Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHDF, which in turn drives the price of the stock up even further. How often is Santhera Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHDF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies TRSBF Short Interest Data AGTX Short Interest Data AGNPF Short Interest Data APLMW Short Interest Data ASPHF Short Interest Data AVCTF Short Interest Data AWKNF Short Interest Data AXIM Short Interest Data BCTXW Short Interest Data CDIOW Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SPHDF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredReal Americans Don’t Wait on Wall Street’s Next MoveWhat's happening in the markets right now should concern every freedom-loving American who's worked hard and s...Premier Gold Co | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santhera Pharmaceuticals Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Santhera Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPHDF Stock Free SPHDF Stock Alerts